Cargando…
Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING
BACKGROUND: Localized radiotherapy (RT) can cause a T cell-mediated abscopal effect on non-irradiated tumor lesions, especially in combination with immune checkpoint blockade. However, this effect is still clinically rare and improvements are highly desirable. We investigated whether triple combinat...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462948/ https://www.ncbi.nlm.nih.gov/pubmed/37640480 http://dx.doi.org/10.1136/jitc-2022-006235 |
_version_ | 1785098145713094656 |
---|---|
author | Wang, Liqun Luo, Ren Onyshchenko, Kateryna Rao, Xi Wang, Meidan Menz, Beatrice Gaedicke, Simone Grosu, Anca-Ligia Firat, Elke Niedermann, Gabriele |
author_facet | Wang, Liqun Luo, Ren Onyshchenko, Kateryna Rao, Xi Wang, Meidan Menz, Beatrice Gaedicke, Simone Grosu, Anca-Ligia Firat, Elke Niedermann, Gabriele |
author_sort | Wang, Liqun |
collection | PubMed |
description | BACKGROUND: Localized radiotherapy (RT) can cause a T cell-mediated abscopal effect on non-irradiated tumor lesions, especially in combination with immune checkpoint blockade. However, this effect is still clinically rare and improvements are highly desirable. We investigated whether triple combination with a low dose of clinically approved liposomal doxorubicin (Doxil) could augment abscopal responses compared with RT/αPD-1 and Doxil/αPD-1. We also investigated whether the enhanced abscopal responses depended on the mitochondrial DNA (mtDNA)/cyclic GMP-AMP synthase (cGAS)/stimulator of interferon genes (STING)/IFN-I pathway. MATERIALS/METHODS: We used Doxil in combination with RT and αPD-1 in two tumor models (B16-CD133 melanoma and MC38 colon carcinoma) with mice bearing two tumors, only one of which was irradiated. Mechanistic studies on the role of the mtDNA/cGAS/STING/IFN-I axis were performed using inhibitors and knockout cells in vitro as well as in mice. RESULTS: Addition of a single low dose of Doxil to RT and αPD-1 strongly enhanced the RT/αPD-1-induced abscopal effect in both models. Complete cures of non-irradiated tumors were mainly observed in triple-treated mice. Triple therapy induced more cross-presenting dendritic cells (DCs) and more tumor-specific CD8(+) T cells than RT/αPD-1 and Doxil/αPD-1, particularly in non-irradiated tumors. Coincubation of Doxil-treated and/or RT-treated tumor cells with DCs enhanced DC antigen cross-presentation which is crucial for inducing CD8(+) T cells. CD8(+) T cell depletion or implantation of cGAS-deficient or STING-deficient tumor cells abolished the abscopal effect. Doxorubicin-induced/Doxil-induced IFNβ1 markedly depended on the cGAS/STING pathway. Doxorubicin-treated/Doxil-treated tumor cells depleted of mtDNA secreted less IFNβ1, of the related T cell-recruiting chemokine CXCL10, and ATP; coincubation with mtDNA-depleted tumor cells strongly reduced IFNβ1 secretion by DCs. Implantation of mtDNA-depleted tumor cells, particularly at the non-irradiated/abscopal site, substantially diminished the Doxil-enhanced abscopal effect and tumor infiltration by tumor-specific CD8(+) T cells. CONCLUSIONS: These data show that single low-dose Doxil can substantially enhance the RT/αPD-1-induced abscopal effect, with a strong increase in cross-presenting DCs and CD8(+) tumor-specific T cells particularly in abscopal tumors compared with RT/αPD-1 and Doxil/αPD-1. Moreover, they indicate that the mtDNA/cGAS/STING/IFN-I axis is important for the immunogenic/immunomodulatory doxorubicin effects. Our findings may be helpful for the planning of clinical radiochemoimmunotherapy trials in (oligo)metastatic patients. |
format | Online Article Text |
id | pubmed-10462948 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-104629482023-08-30 Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING Wang, Liqun Luo, Ren Onyshchenko, Kateryna Rao, Xi Wang, Meidan Menz, Beatrice Gaedicke, Simone Grosu, Anca-Ligia Firat, Elke Niedermann, Gabriele J Immunother Cancer Clinical/Translational Cancer Immunotherapy BACKGROUND: Localized radiotherapy (RT) can cause a T cell-mediated abscopal effect on non-irradiated tumor lesions, especially in combination with immune checkpoint blockade. However, this effect is still clinically rare and improvements are highly desirable. We investigated whether triple combination with a low dose of clinically approved liposomal doxorubicin (Doxil) could augment abscopal responses compared with RT/αPD-1 and Doxil/αPD-1. We also investigated whether the enhanced abscopal responses depended on the mitochondrial DNA (mtDNA)/cyclic GMP-AMP synthase (cGAS)/stimulator of interferon genes (STING)/IFN-I pathway. MATERIALS/METHODS: We used Doxil in combination with RT and αPD-1 in two tumor models (B16-CD133 melanoma and MC38 colon carcinoma) with mice bearing two tumors, only one of which was irradiated. Mechanistic studies on the role of the mtDNA/cGAS/STING/IFN-I axis were performed using inhibitors and knockout cells in vitro as well as in mice. RESULTS: Addition of a single low dose of Doxil to RT and αPD-1 strongly enhanced the RT/αPD-1-induced abscopal effect in both models. Complete cures of non-irradiated tumors were mainly observed in triple-treated mice. Triple therapy induced more cross-presenting dendritic cells (DCs) and more tumor-specific CD8(+) T cells than RT/αPD-1 and Doxil/αPD-1, particularly in non-irradiated tumors. Coincubation of Doxil-treated and/or RT-treated tumor cells with DCs enhanced DC antigen cross-presentation which is crucial for inducing CD8(+) T cells. CD8(+) T cell depletion or implantation of cGAS-deficient or STING-deficient tumor cells abolished the abscopal effect. Doxorubicin-induced/Doxil-induced IFNβ1 markedly depended on the cGAS/STING pathway. Doxorubicin-treated/Doxil-treated tumor cells depleted of mtDNA secreted less IFNβ1, of the related T cell-recruiting chemokine CXCL10, and ATP; coincubation with mtDNA-depleted tumor cells strongly reduced IFNβ1 secretion by DCs. Implantation of mtDNA-depleted tumor cells, particularly at the non-irradiated/abscopal site, substantially diminished the Doxil-enhanced abscopal effect and tumor infiltration by tumor-specific CD8(+) T cells. CONCLUSIONS: These data show that single low-dose Doxil can substantially enhance the RT/αPD-1-induced abscopal effect, with a strong increase in cross-presenting DCs and CD8(+) tumor-specific T cells particularly in abscopal tumors compared with RT/αPD-1 and Doxil/αPD-1. Moreover, they indicate that the mtDNA/cGAS/STING/IFN-I axis is important for the immunogenic/immunomodulatory doxorubicin effects. Our findings may be helpful for the planning of clinical radiochemoimmunotherapy trials in (oligo)metastatic patients. BMJ Publishing Group 2023-08-28 /pmc/articles/PMC10462948/ /pubmed/37640480 http://dx.doi.org/10.1136/jitc-2022-006235 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Clinical/Translational Cancer Immunotherapy Wang, Liqun Luo, Ren Onyshchenko, Kateryna Rao, Xi Wang, Meidan Menz, Beatrice Gaedicke, Simone Grosu, Anca-Ligia Firat, Elke Niedermann, Gabriele Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING |
title | Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING |
title_full | Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING |
title_fullStr | Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING |
title_full_unstemmed | Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING |
title_short | Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING |
title_sort | adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αpd1 therapy depending on tumor cell mitochondrial dna and cgas/sting |
topic | Clinical/Translational Cancer Immunotherapy |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462948/ https://www.ncbi.nlm.nih.gov/pubmed/37640480 http://dx.doi.org/10.1136/jitc-2022-006235 |
work_keys_str_mv | AT wangliqun addingliposomaldoxorubicinenhancestheabscopaleffectinducedbyradiationapd1therapydependingontumorcellmitochondrialdnaandcgassting AT luoren addingliposomaldoxorubicinenhancestheabscopaleffectinducedbyradiationapd1therapydependingontumorcellmitochondrialdnaandcgassting AT onyshchenkokateryna addingliposomaldoxorubicinenhancestheabscopaleffectinducedbyradiationapd1therapydependingontumorcellmitochondrialdnaandcgassting AT raoxi addingliposomaldoxorubicinenhancestheabscopaleffectinducedbyradiationapd1therapydependingontumorcellmitochondrialdnaandcgassting AT wangmeidan addingliposomaldoxorubicinenhancestheabscopaleffectinducedbyradiationapd1therapydependingontumorcellmitochondrialdnaandcgassting AT menzbeatrice addingliposomaldoxorubicinenhancestheabscopaleffectinducedbyradiationapd1therapydependingontumorcellmitochondrialdnaandcgassting AT gaedickesimone addingliposomaldoxorubicinenhancestheabscopaleffectinducedbyradiationapd1therapydependingontumorcellmitochondrialdnaandcgassting AT grosuancaligia addingliposomaldoxorubicinenhancestheabscopaleffectinducedbyradiationapd1therapydependingontumorcellmitochondrialdnaandcgassting AT firatelke addingliposomaldoxorubicinenhancestheabscopaleffectinducedbyradiationapd1therapydependingontumorcellmitochondrialdnaandcgassting AT niedermanngabriele addingliposomaldoxorubicinenhancestheabscopaleffectinducedbyradiationapd1therapydependingontumorcellmitochondrialdnaandcgassting |